Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ANI Names Vice President, Corticotropin Product Development

Executive Summary

ANI Pharmaceuticals, Inc. has appointed Mark J. Ginski vice president, corticotropin product development. Ginski brings over 20 years of industry experience to the integrated specialty pharma company, most recently within Mallinckrodt Pharmaceuticals, where he was senior director, CMC and operations for autoimmune and rare diseases. Prior to this, he held various positions in the area of specialty drug development at Shire Pharmaceuticals, Alba Therapeutics, Cerecor Inc. and Questcor Pharmaceuticals.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC065275

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel